I-131-recombinant Human EGF Has Anti-tumor Effects Against MCF-7 Human Breast Cancer Xenografts with Low Levels of EGFR.
2021.04.01
Li YC, Xu WY, Tan TZ, He S. I-131-recombinant Human EGF Has Anti-tumor Effects Against MCF-7 Human Breast Cancer Xenografts with Low Levels of EGFR. Nucl Med Biol. , 2004 , 31(4):435-440.